medcentral.com

4 days ago | medcentral.com | Racheal Ede

Exposure to colibactin bacteria in early childhood was associated with early-onset colorectal cancer (EOCRC) as colibactin-induced mutations were 3.3 times more prevalent in individuals diagnosed before age 40, compared to those above 70, according to a global study. The growing incidence of early-onset colorectal cancer over the past two decades has raised significant questions about its underlying causes and specific risk factors.

4 days ago | medcentral.com | Heidi Splete

A new form of toxicity has been identified in patients with autoimmune diseases receiving CD19-targeting CAR T-cell therapy, according to data from an observational study of 39 individuals. CD19-targeting chimeric antigen receptor (CAR) T-cell therapy is a relatively new treatment for severe forms of systemic lupus erythematosus (SLE), idiopathic inflammatory myopathy, and systemic sclerosis, although it has a history of use in patients with cancer.

1 week ago | medcentral.com | Torrey Kim

A vast majority of physicians and other clinicians feel burdened by documentation requirements. One study conducted in 2024 noted that nearly three-quarters of healthcare providers said the documentation they had to complete cut into their time caring for patients. And when you aren’t caring for patients, you aren’t bringing in revenue. One way to reduce the documentation burden – and time – is to use medical scribes at your practice.

2 weeks ago | medcentral.com | Racheal Ede

New global consensus recommendations for the identification and treatment of high-risk metabolic dysfunction-associated steatotic liver disease(MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) have been published in the journal Gastroenterology. The increasing prevalence of MASLD and MASH has compelled several national and international societies to develop management guidelines.

3 weeks ago | medcentral.com | Kathleen Doheny

Despite statistics that as many as half a million people in the United States may be diagnosed with Lyme disease each year, many questions and treatment needs remain unmet. Scientists cannot say for sure why some people recover quickly after treatment while others report prolonged and debilitating symptoms. While the standard treatment with the broad-spectrum antibiotic doxycycline can be effective, it can also kill beneficial bacteria.